Thursday, November 30, 2017
[Correspondence] Informing women with endometriosis about ovarian cancer risk
from The Lancet http://ift.tt/2jA1Mrk
via IFTTT
Dimensionality and Reliability of the Central Sensitization Inventory (CSI) in a Pooled Multi-Country Sample
from The Journal of Pain http://ift.tt/2j4Iues
via IFTTT
Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis
from The Journal of Pain http://ift.tt/2BnFH6A
via IFTTT
Wednesday, November 29, 2017
Power through the ages
Power through the ages
Nature 551, 7682 (2017). doi:10.1038/d41586-017-07506-z
Author: Stephanie Pain
From elbow grease to electricity, horsepower to hydropower, energy has played a crucial part in shaping society.
from Nature - Issue - nature.com science feeds http://ift.tt/2neo72R
via IFTTT
Monday, November 27, 2017
Endogenous Pain Modulation Induced by Extrinsic and Intrinsic Psychological Threat in Healthy Individuals
from The Journal of Pain http://ift.tt/2Bs353P
via IFTTT
Sunday, November 26, 2017
Ketamine for chronic non-cancer pain: A meta-analysis and trial sequential analysis of randomized controlled trials
Abstract
Background
Ketamine has been suggested to be efficient in relieving chronic pain. However, there is inconsistency across studies investigating the effect of ketamine for chronic pain management. We aimed to perform a meta-analysis in order to assess the efficacy of this compound during chronic non-cancer pain conditions.
Methods
The study consisted in a meta-analysis of clinical trials comparing ketamine to a placebo during chronic non-cancer pain. The primary endpoint of this study was pain relief 4 weeks after the beginning of treatment. Secondary outcomes were: pain relief 1, 2, 8 and 12 weeks after the beginning of treatment and incidence of psychedelic manifestations.
Results
Six studies were included in this meta-analysis. Overall, 99 patients received ketamine and 96 received placebo. Ketamine did not decrease pain intensity at 4 weeks (MD (on a 0 to 10 scale) = −1.12 [−2.33, 0.09], GRADE evidence: very low). However, analysing studies with no high-risk bias found ketamine to decrease pain intensity at 4 weeks and increased the level of GRADE evidence to moderate. Trial sequential analysis confirmed the overall result and revealed the lack of power of this meta-analysis. Ketamine also decreased pain intensity at all other evaluated points in time. Ketamine increased the incidence of psychedelic manifestations in comparison to placebo.
Conclusion
Results of this meta-analysis found moderate evidence suggesting the efficacy of ketamine during chronic pain. Further studies are warranted to conclude about the effect of ketamine during chronic pain conditions and to determine optimal administration regimes of this agent during this condition.
Significance
Ketamine has been found interesting for managing chronic pain. We performed a meta-analysis aiming to confirm those results. Ketamine was found efficient in alleviating pain up to 12 weeks after the beginning of treatment. However, overall evidence favouring the use of this compound was very low.
from European Journal of Pain http://ift.tt/2BpsDyH
via IFTTT
Thursday, November 23, 2017
[Perspectives] Powerful venom
from The Lancet http://ift.tt/2mWwKil
via IFTTT
Metastatic adenocarcinoma masquerading as panuveitis
from Latest headlines from BMJ http://ift.tt/2jUPCNS
via IFTTT
A teenage girl with lower abdominal pain
from Latest headlines from BMJ http://ift.tt/2mTZh8h
via IFTTT
Tuesday, November 21, 2017
Identifying risk factors for first-episode neck pain: A systematic review
from Musculoskeletal Science & Practice http://ift.tt/2BcDWdi
via IFTTT
The Influence of Social Threat on Pain, Aggression, and Empathy in Women
from The Journal of Pain http://ift.tt/2AlDc8v
via IFTTT
Hijacking the endogenous opioid system to treat pain: who thought it would be so complicated?
from PAIN - Featured Articles - Current Issue Highlights http://ift.tt/2B8opLA
via IFTTT
Discovery of endogenous opioid systems: what it has meant for the clinician's understanding of pain and its treatment
from PAIN - Featured Articles - Current Issue Highlights http://ift.tt/2B8oGOC
via IFTTT
Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation
from PAIN - Featured Articles - Current Issue Highlights http://ift.tt/2B8ogI2
via IFTTT
Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation
from PAIN - Featured Articles - Current Issue Highlights http://ift.tt/2B8ogI2
via IFTTT
Effects of a psychosocial intervention programme combined with exercise in community-dwelling older adults with chronic pain: A randomized controlled trial
Abstract
Background
Although researchers have recommended exercise training and psychosocial intervention to manage chronic pain, an effective intervention for Japanese community-dwelling older adults with chronic pain has not been established. This randomized controlled trial examined whether exercise training combined with psychosocial intervention more effectively improves pain, psychological status and physical activity than does exercise training alone in this population.
Methods
We randomized 128 older adults with chronic pain to either an intervention group (n = 64) involving exercise training combined with psychosocial intervention, or a control group (n = 64) involving only exercise training. Exercise training comprised weekly 60-min sessions for 12 weeks. Psychosocial intervention involved changing participants' focus on pain using self-management education and cognitive behavioural therapy, and participants recorded their daily pain intensity and step counts. Pain intensity, psychological status and physical activity were assessed before and 12 weeks after the intervention.
Results
A time-by-group interaction emerged for psychological status (p = 0.003) and physical activity (p < 0.001), both favouring the intervention group. The intervention group also showed greater improvement in pain intensity at 12 weeks than did the control group (p = 0.007).
Conclusions
Exercise training combined with psychosocial intervention improves key outcome indicators more effectively than does exercise training alone in older adults with chronic pain.
Significance
Although research has shown that combined exercise and psychosocial intervention is optimal for managing chronic pain, our study is the first, to the best of our knowledge, to test a specific intervention of this type in community-dwelling older adults with chronic pain in Japan.
from European Journal of Pain http://ift.tt/2AhdT7u
via IFTTT
Relationship between self-reported cognitive difficulties, objective neuropsychological test performance and psychological distress in chronic pain
Abstract
Background
Persons with chronic pain often report problems with cognitive abilities, such as memory or attention. There is limited understanding of whether objective performance is consistent with subjective reports, and how psychological factors contribute. We aimed to investigate these relationships in a group of patients expressing cognitive concerns, and evaluate the utility of self-report tools for pain management settings.
Method
Participants with chronic pain (n = 41) completed standardized neuropsychological tests, and self-report measures of cognitive functioning, pain, mood and sleep, as part of a broader study investigating cognitive performance in pain.
Results
Average neuropsychological test performance was subtly below normative means (within one standard deviation). Twenty-five percent of the sample scored substantially below age-adjusted norms on one or more objective tests. There were moderate-to-large associations between objective performance (e.g. Trail-Making B) and subjective cognitive complaints (e.g. Everyday Memory Questionnaire – Revised), controlling for age and education level. This was moderated by anxiety, such that subjective–objective relationships were particularly strong in those with higher anxiety. Poorer test performance was associated with higher pain intensity and catastrophizing. Subjective–objective cognition relationships remained after controlling for catastrophizing.
Conclusion
Patients’ self-reported cognitive concerns concurred with objectively measured performance, independent of age, education and catastrophizing. Moreover, those with severe anxiety were more accurate in predicting their cognitive performance. The findings highlight some interesting cognition–mood relationships, and suggest that easy-to-administer questionnaires, such as the Everyday Memory Questionnaire – Revised and the Behavior Rating Inventory of Executive Function – Adult Version, may be useful to capture cognitive concerns in clinical settings.
Significance
Cognitive concerns in chronic pain reflected objective neurocognitive performance. This was moderated by anxiety, such that self-reported cognition was more consistent with objective performance in those with high anxiety. Our findings suggest that reported cognitive concerns should be heeded, and self-report measures may be used clinically to facilitate dialogue about cognitive functioning.
from European Journal of Pain http://ift.tt/2zUYsBp
via IFTTT
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings
Abstract
Cannabinoids have a long record of recreational and medical use and become increasingly approved for pain therapy. This development is based on preclinical and human experimental research summarized in this review. Cannabinoid CB1 receptors are widely expressed throughout the nociceptive system. Their activation by endogenous or exogenous cannabinoids modulates the release of neurotransmitters. This is reflected in antinociceptive effects of cannabinoids in preclinical models of inflammatory, cancer and neuropathic pain, and by nociceptive hypersensitivity of cannabinoid receptor-deficient mice. Cannabis-based medications available for humans mainly comprise Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD) and nabilone. During the last 10 years, six controlled studies assessing analgesic effects of cannabinoid-based drugs in human experimental settings were reported. An effect on nociceptive processing could be translated to the human setting in functional magnetic resonance imaging studies that pointed at a reduced connectivity within the pain matrix of the brain. However, cannabinoid-based drugs heterogeneously influenced the perception of experimentally induced pain including a reduction in only the affective but not the sensory perception of pain, only moderate analgesic effects, or occasional hyperalgesic effects. This extends to the clinical setting. While controlled studies showed a lack of robust analgesic effects, cannabis was nearly always associated with analgesia in open-label or retrospective reports, possibly indicating an effect on well-being or mood, rather than on sensory pain. Thus, while preclinical evidence supports cannabinoid-based analgesics, human evidence presently provides only reluctant support for a broad clinical use of cannabinoid-based medications in pain therapy.
Significance
Cannabinoids consistently produced antinociceptive effects in preclinical models, whereas they heterogeneously influenced the perception of experimentally induced pain in humans and did not provide robust clinical analgesia, which jeopardizes the translation of preclinical research on cannabinoid-mediated antinociception into the human setting.
from European Journal of Pain http://ift.tt/2AjhhyD
via IFTTT
Monday, November 20, 2017
Tactile acuity is reduced in people with chronic neck pain
from Musculoskeletal Science & Practice http://ift.tt/2mMxRBl
via IFTTT
Decompression surgery fails to relieve shoulder impingement in trial
from Latest headlines from BMJ http://ift.tt/2iBPfUH
via IFTTT
Thursday, November 16, 2017
Do Correlates of Pain-Related Stoicism and Cautiousness Differ in Younger and Older People with Advanced Cancer?
from The Journal of Pain http://ift.tt/2hF3BXo
via IFTTT
The swollen pinna
from Latest headlines from BMJ http://ift.tt/2zIRiji
via IFTTT
A man with knee pain after a fall
from Latest headlines from BMJ http://ift.tt/2A3Nnyl
via IFTTT